amrinone has been researched along with Aging in 3 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There was a large variability in the volume of distribution, clearance, and elimination half-life which did not appear to be age-related." | 1.29 | Age-related amrinone pharmacokinetics in a pediatric population. ( Allen-Webb, EM; Banner, W; McGough, EC; Pappas, JB; Ross, MP, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binah, O | 1 |
| Legato, MJ | 1 |
| Danilo, P | 1 |
| Rosen, MR | 1 |
| Allen-Webb, EM | 1 |
| Ross, MP | 1 |
| Pappas, JB | 1 |
| McGough, EC | 1 |
| Banner, W | 1 |
| Harada, K | 1 |
| Ohashi, K | 1 |
| Kumagai, Y | 1 |
| Ohmori, M | 1 |
| Fujimura, A | 1 |
1 trial available for amrinone and Aging
| Article | Year |
|---|---|
Influence of age on venodilator effect of isoproterenol and amrinone.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Aging; Amrinone; Blood Pressure; Cross-Ove | 1996 |
2 other studies available for amrinone and Aging
| Article | Year |
|---|---|
Developmental changes in the cardiac effects of amrinone in the dog.
Topics: Aging; Aminopyridines; Amrinone; Animals; Animals, Newborn; Dogs; Female; Heart Conduction System; M | 1983 |
Age-related amrinone pharmacokinetics in a pediatric population.
Topics: Adolescent; Aging; Amrinone; Child; Child, Preschool; Half-Life; Humans; Infant; Infant, Newborn; In | 1994 |